Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.


Why should you invest in Mabion S.A.?

  • Mabion S.A. is a leading biotechnology company in Poland.
  • It operates on an attractive biosimilar market, one of the most dynamically developing areas in the global pharmaceutical industry.
  • Mabion has been developing an attractive portfolio of biosimilar drugs whose reference drugs have a global reach on a market which is worth over USD 20 billion.
  • The use of cutting edge technologies, such as orbital shaking and disposable technologies, allows Mabion S.A. to achieve high profit margins and an equally impressive level of production efficiency.
  • Our employees have rich experience, both in management and in biotechnology, and the last ten years at Mabion S.A. have turned them into a perfect team.
  • We also have great potential when it comes to establishing partnerships with the biggest players in the global pharmaceutical and biotech industry.
© Mabion S.A. all rights reserved Polityka Prywatności